Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn


Cochlear shares soar after dividend boost

Simone Ziaziaris  |  17 Aug 2017Text size  Decrease  Increase  |  
Email to Friend

Page 1 of 1

SYDNEY - [AAP] Shares in Cochlear (ASX: COH) have soared after the hearing implant maker lifted its final dividend and forecast profit growth in the year ahead.

The company's net profit in the year to June 30 rose 18 per cent from the prior year to $223.6 million, as it achieved strong growth in sales revenue and earnings after launching new products.

Healthier operating cash flows supported a 17 per cent increase in Cochlear's final dividend.

Cochlear said it expects previous investments in product development and market growth to deliver a net profit of between $240 million and $250 million in the 2017/18 financial year, though a stronger Australian dollar is expected to moderate its underlying growth.

"In particular, we expect the launch of the Nucleus 7 Sound Processor, which commences its full market release from September, to contribute to both implant growth and upgrade demand over the coming years," the company said.

Cochlear shares were up $11.63, or 8.2 per cent, at $154.41 at 1330 AEST.

The company's core cochlear implant business, which contributes 62 per cent of sales revenue, achieved 5 per cent revenue growth in 2016/17, as the number of implants sold rose 8 per cent to 32.6 million.

Email to Friend
Market News and Views Sign up today and receive our free Morning Note e-newsletter, daily in your inbox.

Chief executive Chris Smith said Cochlear invested $152 million in 2016/17, or 12 per cent of sales revenue, in research and development, with a pipeline of new products expected to be launched over the coming years.


* Full year net profit up 18pct to $223.6m

* Sales revenue up 7pct to $1.2bn

* Final dividend up 20 cents to $1.40, fully franked


AAP logo image

© [2017] Australian Associated Press Pty Limited (AAP) or its Licensors. This is the Morningstar service with content provided by AAP where indicated. AAP reserves all rights, including copyright, in services provided by it. The information in the service is for personal use only, does not constitute financial product advice (whether general or personal) and may not be re-written, copied, re-sold or re-distributed, framed, linked or otherwise used whether for compensation of any kind or not, without the prior written permission of AAP. You should seek advice from a professional financial adviser before making decision to acquire or dispose of a financial product.

This service is published for general information purposes only without assuming a duty of care. AAP is not in the business of providing financial product advice (whether personal or general advice), and gives no warranty, guarantee or other representation about the accuracy of the information or images contained in this service. AAP is not liable for errors, omissions in, delays or interruptions to or cessation of the services through negligence or otherwise. The globe symbol and "AAP" are registered trademarks.

Email To Friend